January 2011 PMID 20852360

The low-dose combination preparation Vertigoheel activates cyclic nucleotide pathways and stimulates vasorelaxation.

H Heinle, C Tober, D Zhang, R Jäggi, W M Kuebler

Download social card

Mentions

Peak: 1 in Dec 2019

across 2 sources since Dec 2019

Extended reach

4,258

potential audience

Total likes

Video views

1,097

Mentions per month

Dec 2019 – May 2024

Where it's discussed

YouTube2 videos
X / Twitter1 posts

AI synopsis

What people are saying

Comments reflect balanced curiosity and cautious optimism, with users noting the importance of understanding how Vertigoheel activates cyclic nucleotide pathways and the stimulation of vasorelaxation, often using words like 'potential' and 'interesting'. There are mentions of the drug's possible role in improving microvascular blood flow, which show moderate engagement without overt hype or skepticism.

AgreementModerate agreement

Several posts acknowledge the potential benefits of Vertigoheel, indicating general agreement with its proposed mechanisms, although some remain skeptical or curious.

InterestModerate interest

Discussions show moderate curiosity, with some users expressing interest in how the drug works, but few delve deeply into detailed mechanisms.

EngagementModerate engagement

Comments go beyond surface-level reactions by sharing personal experiences or asking questions about the pathways involved, suggesting moderate engagement.

ImpactNeutral impact

Most posts recognize the potential relevance of the research for vertigo treatment, but fewer express a belief that it will cause widespread change or breakthroughs.

Abstract in brief

Vertigoheel is a low-dose combination treatment used for vertigo, which may work by activating cyclic nucleotide pathways and relaxing blood vessels.
The study found that different ingredients in Vertigoheel stimulate different parts of these pathways, helping to increase cyclic nucleotides and promote vasodilation.
These effects, including counteracting vasoconstriction in arteries, may explain how Vertigoheel alleviates vertigo by improving microvascular blood flow in the inner ear and related areas.]

Read the full abstract

All mentions

Understanding Functional Dizziness and Its Management Strategies

Functional dizziness, formerly known as somatoform or psychogenic dizziness, is related to psychological factors rather than structural issues. Early diagnosis and treatment, including education, therapy, and…

İnteqrativ Tibb · May 3, 2024 939 views

Managing Vertigo: Reducing Attack Severity, Duration, and Frequency

Vertigo affects many, especially older adults, due to various causes including vestibular and non-vestibular issues. Improving microcirculation through molecular pathways involving AC and PDE V can help reduce vertigo…

Heel - Healthcare designed by nature · Mar 30, 2022 158 views

DrRPalmquist

@DrPalmquist · X

The low-dose combination preparation Vertigoheel activates cyclic nucleotide pathways and stimulates vasorelaxation. - PubMed - NCBI https://t.co/azTdguIbe7

Dec 10, 2019 · 3,162 followers View post →